Cape Coast Hepatitis B and C Screening and treatment eligibility assessment dataset

Published: 1 May 2024| Version 1 | DOI: 10.17632/4d6xynfdsy.1
Oheneba C K Hagan


Accessibility to treatment for individuals infected with hepatitis B and C remain poor in LMICs including Ghana. Poor rate of diagnosis and assessment for treatment remain the 2 most important factors attributable to this problem. Improving the screening rate and making the treatment eligibility assessment affordable will improve the accessibility to treatment. The study site was at a primary health care facility where regular screening is undertaken for walk-ins and the referred. The dataset are 2, comprising the screened the data from retrospective review of records and a cross-sectional study of treatment eligibility assessment for those diagnosed with hepatitis B. Genotyping was also undertaken and the chromatograph of the Sanger sequencing has also been added here



Korle Bu Teaching Hospital, University of Cape Coast


Viral Hepatitis, Hepatitis B, Hepatitis C


University of Cape Coast Directorate of Research, Innovation and Consultancy